Use of the Self-Administered Eczema Area and Severity Index by parent caregivers: results of a validation study

被引:66
作者
Housman, TS
Patel, MJ
Camacho, F
Feldman, SR
Fleischer, AB
Balkrishnan, R
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Dept Dermatol, Winston Salem, NC 27157 USA
[2] Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA
关键词
assessment; atopic dermatitis; Eczema Area and Severity Index; eczema; epidemiology; Self-Administered Eczema Area and Severity Index; validity;
D O I
10.1046/j.1365-2133.2002.05031.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background The Eczema Area and Severity Index (EASI) is used by dermatological investigators world-wide to assess eczema disease severity. EASI measures are, however, time-consuming and require trained personnel, thereby limiting its application to large-scale epidemiological studies. Additionally, the use of self-assessed severity indices in dermatology is restricted to adult subjects and conditions, thereby not addressing the needs of paediatric patients. Objectives To develop and validate an instrument for a caregiver's self-assessment of the severity of his/her child's atopic dermatitis (AD), the Self-Administered EASI (SA-EASI). Methods Trained investigators performed a modified EASI assessment on the same day as an SA-EASI was obtained from 47 caregivers of children with AD. Results The SA-EASI was found to be a valid measure of the severity of AD. Total, acute and chronic SA-EASI scores predicted total, acute and chronic modified EASI scores (P < 0.0001). SA-EASI body surface area (BSA) scores predicted EASI BSA scores (P < 0.0001). SA-EASI pruritus scores correlated with the acute, chronic and total EASI scores (P = 0.0001). Conclusions The SA-EASI may provide caregivers the means to report the severity of their child's skin disease objectively. The high correlation with the EASI score observed in this sample implies that statistical inferences with the SA-EASI will be valid for large populations. In future studies, this will permit analysis of the relationship of skin disease severity to such measures as quality of life, disability, patient satisfaction and the costs of various therapies. Moreover, this SA-EASI instrument may allow older children, over 12 years old, to assess the severity of their AD.
引用
收藏
页码:1192 / 1198
页数:7
相关论文
共 21 条
[11]   The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis [J].
Hanifin, JM ;
Thurston, M ;
Omoto, M ;
Cherill, R ;
Tofte, SJ ;
Graeber, M .
EXPERIMENTAL DERMATOLOGY, 2001, 10 (01) :11-18
[12]   Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, Efficacy [J].
Hanifin, JM ;
Ling, MR ;
Langley, R ;
Breneman, D ;
Rafal, E .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (01) :S28-S38
[13]  
HANIFIN JM, 1989, ACTA DERM-VENEREOL, P28
[14]   First experience of topical SDZ ASM 981 in children with atopic dermatitis [J].
Harper, J ;
Green, A ;
Scott, G ;
Gruendl, E ;
Dorobek, B ;
Cardno, M ;
Burtin, P .
BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (04) :781-787
[15]   PSYCHOMETRIC CONSIDERATIONS IN EVALUATING HEALTH-RELATED QUALITY-OF-LIFE MEASURES [J].
HAYS, RD ;
ANDERSON, R ;
REVICKI, D .
QUALITY OF LIFE RESEARCH, 1993, 2 (06) :441-449
[16]  
Lawson V, 1998, BRIT J DERMATOL, V138, P107
[17]   SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis [J].
Luger, T ;
Van Leent, EJM ;
Graeber, M ;
Hedgecock, S ;
Thurston, M ;
Kandra, A ;
Berth-Jones, J ;
Bjerke, J ;
Christophers, E ;
Knop, J ;
Knulst, AC ;
Morren, M ;
Morris, A ;
Reitamo, S ;
Roed-Petersen, J ;
Schoepf, E ;
Thestrup-Pedersen, K ;
Van der Valk, PGM ;
Bos, JD .
BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (04) :788-794
[18]   Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis [J].
Reitamo, S ;
Wollenberg, A ;
Schöpf, E ;
Perrot, JL ;
Marks, R ;
Ruzicka, T ;
Christophers, E ;
Kapp, A ;
Lahfa, M ;
Rubins, A ;
Jablonska, S ;
Rustin, M .
ARCHIVES OF DERMATOLOGY, 2000, 136 (08) :999-1006
[19]   CLINICAL EFFECTS OF DIAPER TYPES ON THE SKIN OF NORMAL INFANTS AND INFANTS WITH ATOPIC-DERMATITIS [J].
SEYMOUR, JL ;
KESWICK, BH ;
HANIFIN, JM ;
JORDAN, WP ;
MILLIGAN, MC .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1987, 17 (06) :988-997
[20]   DOUBLE-BLIND, CONTROLLED, CROSSOVER STUDY OF CYCLOSPORINE IN ADULTS WITH SEVERE REFRACTORY ATOPIC-DERMATITIS [J].
SOWDEN, JM ;
BERTHJONES, J ;
ROSS, JS ;
MOTLEY, RJ ;
MARKS, R ;
FINLAY, AY ;
SALEK, MS ;
GRAHAMBROWN, RAC ;
ALLEN, BR ;
CAMP, RDR .
LANCET, 1991, 338 (8760) :137-140